Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash flows from operating activities:
Net loss	$ (6,920,540)	$ (4,844,021)
Adjustments to reconcile net loss to net cash used in operating activities:
Impairment of goodwill	2,938,653
Depreciation expense	9,621	6,764
Amortization of intangible assets	145,124	589,619
Amortization of deferred license costs	10,196
Amortization of debt discount	105,770
Amortization of debt issuance costs	73,225
Bad debt expense	(54,000)	810,580
Interest income on short-term investment		(4)
Stock-based compensation	729,404	396,214
Loss on asset disposal	52,039
Loss on equity affiliates		3,626
Changes in operating assets and liabilities:
Accounts receivable	699,141	448,969
Cost and estimated earnings in excess of billings on uncompleted contracts	154,310	(199,150)
Prepaid expenses and other current assets	912,749	(802,797)
Accounts payable and accrued expenses	(301,457)	476,127
Billings in excess of costs and estimated earnings on uncompleted contracts	(1,165,930)	(338,161)
Deferred long-term asset charge	(203,926)
Net cash used in operating activities	(2,815,621)	(3,452,234)
Cash flows provided by investing activities:
Proceeds from short-term investment		30,037
Purchase of property, plant and equipment	(2,070)	(71,306)
Purchase of intangible asset		(5,300)
Investment in and advances to equity affiliates		(3,626)
Net cash used in investing activities	(2,070)	(50,195)
Cash flows from financing activities:
Proceeds from public stock offering, net of offering costs	3,253,962
Proceeds from short-term note payable	375,000
Payments on short-term note payable	480,770
Payments on debt issuance costs	73,225
Net cash provided by financing activities	3,074,967
Net increase (decrease) in cash and cash equivalents	257,276	(3,502,429)
Cash and cash equivalents - beginning of period	1,368,395	4,870,824
Cash and cash equivalents - end of period	1,625,671	1,368,395
Cash paid during the period for:
Cash paid during the period for Interest	105,770
Supplemental disclosure of non-cash operating activities:
Non-cash conversion of accrued salary to restricted stock units	$ 217,256